3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
3
Renal Insufficiency, Chronic
2
Prostatic Neoplasms
2
Uterine Prolapse
1
Urologic Neoplasms
1
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neuromuscular Blockade
1
Muscle Hypotonia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Melanoma
1
Lung Neoplasms
1
Leiomyoma
1
Intraabdominal Infections
1
Intestinal Obstruction
1
Interventions
Oxaliplatin
270
Bevacizumab
260
Fluorouracil
249
Irinotecan
240
Leucovorin
218
Capecitabine
196
Cetuximab
161
Colonoscopy
74
Folfox protocol
70
Panitumumab
64
regorafenib
62
Drug Therapy
52
Radiotherapy
50
HMPL-013
50
Blood Specimen Collection
45
trifluridine tipiracil drug combination
43
pembrolizumab
41
Surveys and Questionnaires
35
Standard of Care
35
Nivolumab
34
Neoadjuvant Therapy
34
Surgical Procedures, Operative
33
Magnetic Resonance Spectroscopy
31
IFL protocol
27
Trifluridine
26
Interviews as Topic
26
Celecoxib
26
XELOX
25
Early Intervention, Educational
24
Specimen Handling
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colorectal Neoplasms
×
Rocuronium
×
Clear all
NCT02327494
2015-01-07
OXYMUBLOC
Hospital Universitari de Bellvitge
Unknown
70 enrolled